Guided by its Nordic ethos, the contract development and manufacturing organization (CDMO) has built a reputation for delivering high-quality work on time and on budget to a global client base.
CDMO Rentschler Biopharma is moving out of the cell and gene therapy space and putting more of its chips behind biologics. The strategic shift means that the company will end operations at its ...
Although Lonza posted slightly lower sales than analysts had expected in 2024, the Swiss CDMO suggested in its year-end report that it's in a stronger position going into 2025 thanks to improved ...
By investing in two technology platforms, the South Korea-based contract development and manufacturing organization (CDMO) has positioned itself to support external clients and its two biotech ...
Laughing Water Capital highlighted stocks like Avid Bioservices, Inc. (NASDAQ:CDMO), in the fourth quarter 2024 investor letter. Avid Bioservices, Inc. (NASDAQ:CDMO) is a contract development and ...
Mails Letter to Stockholders Highlighting the Significant, Immediate and Certain Cash Value the Transaction Delivers to StockholdersTUSTIN, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Avid ...
The growing investment in India's CDMO sector indicates confidence in India’s pharmaceutical sector and its potential - A detailed analysis. With the U.S. increasingly adopting an anti-China ...